Tasquinimod

Overview

Tasquinimod is an oral S100A9 inhibitor being evaluated in multiple myeloma.

SparkCures ID 382
Developed By Active Biotech AB
Generic Name Tasquinimod
Additional Names ABR-215050, CID 54682876

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.